{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-23-053665","form_type":"8-K","ticker":"ADMA","cik":"0001368514","company_name":"ADMA BIOLOGICS, INC.","filed_at":"2023-11-16T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.773197+00:00","generated_at":"2026-06-08T01:01:20.426209+00:00","sec_items":["8.01","9.01"],"event_type":"regulatory","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"ADMA receives FDA approval for 10th plasma collection center; achieves plasma supply self-sufficiency","bullets":["FDA approval for Laurel, MD facility (10th ADMA BioCenters center) to introduce source plasma into interstate commerce.","Facility began operations and collection in H1 2023; now licensed for further manufacturing in the U.S.","Management says approval accomplishes goal of plasma self-sufficiency, supporting revenue growth and profitability outlook.","Center uses Haemonetics NexSys Persona® collection system; expects ~50 staff at full capacity."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-23-053665","json":"https://secwatch.observer/filing/0001140361-23-053665.json","markdown":"https://secwatch.observer/filing/0001140361-23-053665.md","text":"https://secwatch.observer/filing/0001140361-23-053665.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123053665/0001140361-23-053665-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1368514/000114036123053665/ef20014835_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T01:01:20.426209+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}